Cargando…
AMP Kinase Activation is Selectively Disrupted in the Ventral Midbrain of Mice Deficient in Parkin or PINK1 Expression
Parkinson’s disease (PD) is a prevalent neurodegenerative movement disorder that is characterized pathologically by the progressive loss of dopaminergic (DA) neurons in the substantia nigra pars compacta (SNpc) of the midbrain. Despite intensive research, the etiology of PD remains poorly understood...
Autores principales: | Hang, Liting, Thundyil, John, Goh, Geraldine W. Y., Lim, Kah-Leong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394446/ https://www.ncbi.nlm.nih.gov/pubmed/30411223 http://dx.doi.org/10.1007/s12017-018-8517-7 |
Ejemplares similares
-
Superoxide drives progression of Parkin/PINK1-dependent mitophagy following translocation of Parkin to mitochondria
por: Xiao, Bin, et al.
Publicado: (2017) -
Correction: Superoxide drives progression of Parkin/PINK1-dependent mitophagy following translocation of Parkin to mitochondria
por: Xiao, Bin, et al.
Publicado: (2018) -
AF-6 is a positive modulator of the PINK1/parkin pathway and is deficient in Parkinson's disease
por: Haskin, Joseph, et al.
Publicado: (2013) -
Parkin Regulation and Neurodegenerative Disorders
por: Zhang, Cheng-Wu, et al.
Publicado: (2016) -
MUL1 acts in parallel to the PINK1/parkin pathway in regulating mitofusin and compensates for loss of PINK1/parkin
por: Yun, Jina, et al.
Publicado: (2014)